Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study ; volume:13 ; number:5 ; day:10 ; month:7 ; year:2024 ; pages:1203-1218 ; date:10.2024
Pain and therapy ; 13, Heft 5 (10.7.2024), 1203-1218, 10.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
True, David
Mullin, Kathleen
Croop, Robert
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40122-024-00626-1
- URN
-
urn:nbn:de:101:1-2411262125473.429639554223
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- True, David
- Mullin, Kathleen
- Croop, Robert
- SpringerLink (Online service)
Other Objects (12)
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study
Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Galcanezumab in patients with episodic migraine: results from the open-label period of the phase 3 PERSIST study
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study